Neoplasma Vol.54, p.353-358, 2007
|
| Title: Prognostic factors in stage-i (T1N0) breast carcinoma patients: who needs
adjuvant systemic treatment? |
| Author: E. YILDIRIM, U. BERBEROGLU |
|
Abstract: There is no consensus about the need of adjuvant therapy in T1N0 breast carcinoma patients. To select a subgroup of these
patients who may benefit from adjuvant systemic therapy, prognostic factor analyses were carried out using chi-square test
and Cox regression analysis in 187 patients’ data in this retrospective study. Primary endpoint was distant metastasis (DM).The
multivariate Cox analysis showed that age group (≤35 years vs >35 years, p=0.01; Hazard Ratio [HR], 15.4; 95% Confidence
Interval [CI], 1.8-133.0), tumor size (>1 cm vs ≤1 cm, p=0.002; HR,3.5; CI:1.2-13.4) and LVI (yes vs no, p=0.002; HR,34.7;
CI:3.6-326.0) were strongly associated with DM. From this analysis, a risk estimation model for DM was constructed.
Whereas patients at low risk had a 96% distant metastasis-free survival, this rate for those at high risk had a 37% (p<0.00001).
According to the proposed model including age, tumor size and LVI, the patients at high risk might benefit from adjuvant
systemic therapy.
|
|
| Keywords: breast carcinoma, stage 1, prognostic factors, risk estimation, adjuvant therapy. |
| Year: 2007, Volume: 54, Issue: |
Page From: 353, Page To: 358 |
|
|
|
|
|
 download file |
|
|
|
|
